Loading clinical trials...

Intracranial Stimulation Mapping In Epilepsy | Clinical Trials | Clareo Health

RECRUITINGNA

Intracranial Stimulation Mapping In Epilepsy

Intracranial Stimulation Mapping In Epilepsy -The InStim Study

NCT05290610•University of Minnesota

Summary

This is a single group prospective study to determine the feasibility for generating brain maps that localize cerebral functions and inter-regional information flow in partial epilepsy in adult patients.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Male or female 18 years and older at screening.
•Written informed consent is obtained from the participant to comply with the requirements of the study.
•Stated willingness to comply with all study procedures and availability for the duration of the study
•Currently undergoing clinically indicated intracranial EEG monitoring for planning of epilepsy surgery in the University of Minnesota/MINCEP program.

Exclusion Criteria

•Pregnancy ruled out prior to approval for intracranial EG monitoring.
•Persons who are rendered temporarily or permanently invulnerable by inability to understand the research due to study complexity, cognitive impairment, or by inability to make independent decisions owing to University of Minnesota or to Fairview health services.

Locations (1)

University of Minnesota

Minneapolis, Minnesota, United States

Key Dates

Start Date

June 1, 2022

Primary Completion Date

June 1, 2026

Completion Date

September 1, 2026

Last Updated

April 17, 2025

Enrollment

ESTIMATED participants

Conditions

Epilepsy

Interventions

Functional mapping

OTHER

Contacts

Matthew Maple

CONTACT

612-946-1424 maple036@umn.edu

Thalamus Seizure Detection With a Deep Brain Stimulator System

NCT06700356

Epilepsy; Seizure

View study

RECRUITINGPHASE1

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

NCT02531880

Epilepsy

View study

RECRUITINGNA

Intracranial Investigation of Neural Circuity Underlying Human Mood

NCT05871372

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 17, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Intracranial Stimulation Mapping In Epilepsy

Inclusion Criteria

Exclusion Criteria

Thalamus Seizure Detection With a Deep Brain Stimulator System

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

Intracranial Investigation of Neural Circuity Underlying Human Mood

Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment

AI-Based Mobile Intervention on Medication Non-Adherence and Transition

MEHMO Natural History and Biomarkers